Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,298
archived clinical trials in
Insomnia Sleep Studies

Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
CCOP - Wichita
mi
from
Wichita, KA
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Foote Memorial Hospital
mi
from
Jackson, MI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Foote Memorial Hospital
mi
from
Jackson, MI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Mercy Memorial Hospital - Monroe
mi
from
Monroe, MI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Mercy Memorial Hospital - Monroe
mi
from
Monroe, MI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
St. John Macomb Hospital
mi
from
Warren, MI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
St. John Macomb Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
St. John's Regional Health Center
mi
from
Springfield, MO
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
St. John's Regional Health Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Cox Medical Center
mi
from
Springfield, MO
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Cox Medical Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Saint Peter's Community Hospital
mi
from
Helena, MT
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Saint Peter's Community Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Montana Cancer Specialists
mi
from
Missoula, MT
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Montana Cancer Specialists
mi
from
Missoula, MT
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Wayne Memorial Hospital, Incorporated
mi
from
Goldsboro, NC
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Wayne Memorial Hospital, Incorporated
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Margaret R Pardee Memorial Hospital
mi
from
Hendersonville, NC
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Margaret R Pardee Memorial Hospital
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Doctors Hospital at Ohio Health
mi
from
Columbus, OH
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Doctors Hospital at Ohio Health
mi
from
Columbus, OH
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Good Samaritan Hospital
mi
from
Dayton, OH
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Good Samaritan Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
CCOP - Dayton
mi
from
Dayton, OH
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
WellSpan Health-York Hospital
mi
from
York, PA
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
WellSpan Health-York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
AnMed Cancer Center
mi
from
Anderson, SC
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
AnMed Cancer Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Marshfield Clinic Cancer Care at Regional Cancer Center
mi
from
Eau Claire, WI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Marshfield Clinic Cancer Care at Regional Cancer Center
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Marshfield Clinic - Lakeland Center
mi
from
Minocqua, WI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Marshfield Clinic - Lakeland Center
mi
from
Minocqua, WI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Marshfield Clinic - Indianhead Center
mi
from
Rice Lake, WI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Marshfield Clinic - Indianhead Center
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Marshfield Clinic at Saint Michael's Hospital
mi
from
Stevens Point, WI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Marshfield Clinic at Saint Michael's Hospital
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Oncare Hawaii, Incorporated - Pali Momi
mi
from
'Aiea, HI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Oncare Hawaii, Incorporated - Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated:  7/25/2017
Pali Momi Medical Center
mi
from
'Aiea, HI
Home-Based Programs for Improving Sleep in Cancer Survivors
A Randomized Phase II Trial Evaluating Two Non-pharmacologic Interventions in Cancer Survivors for the Treatment of Sleep-wake Disturbances
Status: Enrolling
Updated: 7/25/2017
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  8/7/2017
GSK Investigational Site
mi
from
San Diego, CA
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 8/7/2017
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  8/7/2017
GSK Investigational Site
mi
from
Atlanta, GA
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 8/7/2017
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  8/7/2017
GSK Investigational Site
mi
from
New York, NY
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 8/7/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  8/7/2017
GSK Investigational Site
mi
from
Durham, NC
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 8/7/2017
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  8/7/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 8/7/2017
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  8/7/2017
GSK Investigational Site
mi
from
Cincinnati, OH
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 8/7/2017
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  8/7/2017
GSK Investigational Site
mi
from
Philadelphia, PA
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of GW679769 (30mg and 90mg) on Sleep Continuity, PSG Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 8/7/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Electrophysiologic Changes in Blacks Treated With CBT for Insomnia
Status: Enrolling
Updated:  9/12/2017
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Electrophysiologic Changes in Blacks Treated With CBT for Insomnia
Status: Enrolling
Updated: 9/12/2017
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
The Effect of Pseudoephedrine on Rhinitis and Sleep
The Effect of Pseudoephedrine on Rhinitis and Sleep
Status: Enrolling
Updated:  9/20/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
The Effect of Pseudoephedrine on Rhinitis and Sleep
The Effect of Pseudoephedrine on Rhinitis and Sleep
Status: Enrolling
Updated: 9/20/2017
Penn State College of Medicine, Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
REM Medical Clinical Research
mi
from
Tucson, AZ
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
REM Medical Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
AV Institute, Inc.
mi
from
Carson, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
AV Institute, Inc.
mi
from
Carson, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Clinical Innovations, Inc
mi
from
Costa Mesa, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Clinical Innovations, Inc
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Sun Valley Research Center
mi
from
Imperial, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Sun Valley Research Center
mi
from
Imperial, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Excell Research, Inc.
mi
from
Oceanside, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
North County Clinical Research (NCCR)
mi
from
Oceanside, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
North County Clinical Research (NCCR)
mi
from
Oceanside, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Pacific Clinical Research Medical Group
mi
from
Orange, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Pacific Clinical Research Medical Group
mi
from
Orange, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
SDS Clinical Trials
mi
from
Orange, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
SDS Clinical Trials
mi
from
Orange, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Clinical Innovations Inc.
mi
from
Riverside, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Clinical Innovations Inc.
mi
from
Riverside, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Clinical Innovations
mi
from
San Diego, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Clinical Innovations
mi
from
San Diego, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Neuropsychiatric Research Center of Orange County
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Apex Research Institute
mi
from
Santa Ana, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Apex Research Institute
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated:  9/25/2017
Clinical Innovations, Inc.
mi
from
Santa Ana, CA
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
A Long Term, Open-Label, Safety Study of Eszopiclone in Children (6 to 11 Years) and Adolescents (12 to 17 Years) With Attention Deficit/Hyperactivity Disorder Associated Insomnia
Status: Enrolling
Updated: 9/25/2017
Clinical Innovations, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials